Critical Insights From Clarivate Analyst Ratings: What You Need To Know
Portfolio Pulse from Benzinga Insights
Clarivate (NYSE:CLVT) has seen a diverse range of analyst ratings over the last three months, with a recent shift towards more bullish perspectives. The average 12-month price target for CLVT has been adjusted to $7.9, down from $9.10, indicating a 13.19% decrease. Analysts from firms including Goldman Sachs, Morgan Stanley, Barclays, RBC Capital, and Oppenheimer have lowered their price targets, reflecting adjustments based on market conditions and company performance. Clarivate's financial indicators show a lower market capitalization, below-average revenue growth, and challenges in profitability and asset utilization.
May 09, 2024 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Clarivate's analyst ratings have shown a recent shift towards bullishness, but the average 12-month price target has decreased to $7.9. Financial challenges include lower market cap, revenue growth, and profitability.
The decrease in the average price target and the outlined financial challenges, such as lower market capitalization, below-average revenue growth, and poor profitability metrics, suggest potential short-term negative impact on CLVT's stock price. The mixed analyst ratings, while showing some bullish sentiment, may not be enough to counteract the concerns raised by the financial indicators.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100